It is important to highlight that in ACTH-secreting pituitary tumors, responsible for pituitary-dependent CD, only a small cell population responds to conventional treatment with dopamine agonists or somatostatin analogs, and transsphenoidal surgery remains the primary therapeutic option. This evidence concerns the gene POMC and pituitary tumor.